163 related articles for article (PubMed ID: 38224333)
1. Somatostatin receptors and the associated intracellular machinery: the two sides of the coin.
Campana C; Iyer AM; Ferone D; Gatto F; Hofland LJ
J Endocrinol; 2024 Mar; 260(3):. PubMed ID: 38224333
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies.
Gatto F; Arvigo M; Ferone D
J Endocrinol Invest; 2020 Nov; 43(11):1543-1553. PubMed ID: 32557353
[TBL] [Abstract][Full Text] [Related]
3. Internalization of somatostatin receptors in brain and periphery.
Csaba Z; Dournaud P
Prog Mol Biol Transl Sci; 2023; 196():43-57. PubMed ID: 36813365
[TBL] [Abstract][Full Text] [Related]
4. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms.
Gatto F; Barbieri F; Arvigo M; Thellung S; Amarù J; Albertelli M; Ferone D; Florio T
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412614
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2--clinical implications.
Cakir M; Dworakowska D; Grossman A
J Cell Mol Med; 2010 Nov; 14(11):2585-91. PubMed ID: 20629988
[No Abstract] [Full Text] [Related]
6. [
Giovannini E; Giovacchini G; Borsò E; Lazzeri P; Riondato M; Leoncini R; Duce V; Ciarmiello A
Curr Radiopharm; 2019; 12(1):11-22. PubMed ID: 30539709
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms.
Cantone MC; Dicitore A; Vitale G
J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33535394
[TBL] [Abstract][Full Text] [Related]
8. Agonist-biased trafficking of somatostatin receptor 2A in enteric neurons.
Zhao P; Canals M; Murphy JE; Klingler D; Eriksson EM; Pelayo JC; Hardt M; Bunnett NW; Poole DP
J Biol Chem; 2013 Sep; 288(36):25689-25700. PubMed ID: 23913690
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer.
Klomp MJ; Dalm SU; de Jong M; Feelders RA; Hofland J; Hofland LJ
Rev Endocr Metab Disord; 2021 Sep; 22(3):495-510. PubMed ID: 33085037
[TBL] [Abstract][Full Text] [Related]
10. Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.
Pöll F; Lehmann D; Illing S; Ginj M; Jacobs S; Lupp A; Stumm R; Schulz S
Mol Endocrinol; 2010 Feb; 24(2):436-46. PubMed ID: 20051480
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin and its receptors contribute in a tissue-specific manner to the sex-dependent metabolic (fed/fasting) control of growth hormone axis in mice.
Córdoba-Chacón J; Gahete MD; Castaño JP; Kineman RD; Luque RM
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E46-54. PubMed ID: 20943754
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin and somatostatin receptor physiology.
Barnett P
Endocrine; 2003 Apr; 20(3):255-64. PubMed ID: 12721505
[TBL] [Abstract][Full Text] [Related]
13. The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors.
Vitali E; Piccini S; Trivellin G; Smiroldo V; Lavezzi E; Zerbi A; Pepe G; Lania AG
Mol Cell Endocrinol; 2021 May; 527():111226. PubMed ID: 33675866
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin analogs and radiopeptides in cancer therapy.
Froidevaux S; Eberle AN
Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036
[TBL] [Abstract][Full Text] [Related]
15. Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges.
Refardt J; Hofland J; Kwadwo A; Nicolas GP; Rottenburger C; Fani M; Wild D; Christ E
Rev Endocr Metab Disord; 2021 Sep; 22(3):581-594. PubMed ID: 32495250
[TBL] [Abstract][Full Text] [Related]
16. Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.
Tulipano G; Stumm R; Pfeiffer M; Kreienkamp HJ; Höllt V; Schulz S
J Biol Chem; 2004 May; 279(20):21374-82. PubMed ID: 15001578
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.
Fani M; Mueller A; Tamma ML; Nicolas G; Rink HR; Cescato R; Reubi JC; Maecke HR
J Nucl Med; 2010 Nov; 51(11):1771-9. PubMed ID: 20956465
[TBL] [Abstract][Full Text] [Related]
18. Intracellular trafficking of somatostatin receptors.
Jacobs S; Schulz S
Mol Cell Endocrinol; 2008 May; 286(1-2):58-62. PubMed ID: 18045773
[TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling.
Ungefroren H; Künstner A; Busch H; Franzenburg S; Luley K; Viol F; Schrader J; Konukiewitz B; Wellner UF; Meyhöfer SM; Keck T; Marquardt JU; Lehnert H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555512
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin and somatostatin receptors: from basic concepts to clinical applications.
De Martino MC; Hofland LJ; Lamberts SW
Prog Brain Res; 2010; 182():255-80. PubMed ID: 20541669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
